These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38336372)

  • 1. Assessment of sentinel Lymph node mapping with different volumes of Indocyanine green in early-stage ENdometrial cancer: the ALIEN study.
    Mauro J; Raimondo D; Di Martino G; Gasparri ML; Restaino S; Neola D; Clivio L; Calidona C; Fruscio R; Vizzielli G; Uccella S; Papadia A; Seracchioli R; Buda A
    Int J Gynecol Cancer; 2024 Jun; 34(6):824-829. PubMed ID: 38336372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study - a multicentric analysis of predictors of failed mapping.
    Sozzi G; Fanfani F; Berretta R; Capozzi VA; Uccella S; Buono N; Giallombardo V; Di Donna MC; Monterossi G; Restaino S; Capasso I; Dinoi G; Scambia G; Chiantera V
    Int J Gynecol Cancer; 2020 Nov; 30(11):1713-1718. PubMed ID: 32868384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
    Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
    Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node mapping in endometrial cancer: performance of hysteroscopic injection of tracers.
    Martinelli F; Ditto A; Bogani G; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Raspagliesi F
    Int J Gynecol Cancer; 2020 Mar; 30(3):332-338. PubMed ID: 31911536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
    Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
    Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer.
    Body N; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
    Gynecol Oncol; 2018 Aug; 150(2):267-273. PubMed ID: 29909967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon nanoparticles combined with indocyanine green for sentinel lymph node detection in endometrial carcinoma.
    Liang S; Wang Z; Chen J; Yang X; Liang X; Sun X; Li X; Zhou R; Li Y; Wang J
    J Surg Oncol; 2021 Sep; 124(3):411-419. PubMed ID: 34086291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: predictors of unsuccessful mapping.
    Tortorella L; Casarin J; Multinu F; Cappuccio S; McGree ME; Weaver AL; Langstraat CL; Keeney GL; Kumar A; Melis GB; Angioni S; Scambia G; Mariani A; Glaser GE
    Gynecol Oncol; 2019 Oct; 155(1):34-38. PubMed ID: 31402166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99
    Papadia A; Zapardiel I; Bussi B; Ghezzi F; Ceccaroni M; De Ponti E; Elisei F; Imboden S; de la Noval BD; Gasparri ML; Di Martino G; De Santiago J; Mueller M; Vecchione F; Dell'Orto F; Buda A
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):475-480. PubMed ID: 27812854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between laparoscopic and robotic surgery for sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging.
    Chaowawanit W; Campbell V; Wilson E; Chetty N; Perrin L; Jagasia N; Barry S
    J Obstet Gynaecol; 2021 May; 41(4):642-646. PubMed ID: 32812452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Indocyanine Green and Tc
    Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
    Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study using indocyanine green and patent blue dye for sentinel lymph node biopsy in patients with early-stage cervical cancer.
    Wess B; Kohler C; Plaikner A; El-Safadi S; Schwandner T; Meinhold-Heerlein I; Favero G
    Int J Gynecol Cancer; 2024 May; 34(5):675-680. PubMed ID: 38485222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study.
    Rossi EC; Kowalski LD; Scalici J; Cantrell L; Schuler K; Hanna RK; Method M; Ade M; Ivanova A; Boggess JF
    Lancet Oncol; 2017 Mar; 18(3):384-392. PubMed ID: 28159465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure.
    Eoh KJ; Lee YJ; Kim HS; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Surg Oncol; 2018 Sep; 27(3):514-519. PubMed ID: 30217312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis.
    Bodurtha Smith AJ; Fader AN; Tanner EJ
    Am J Obstet Gynecol; 2017 May; 216(5):459-476.e10. PubMed ID: 27871836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
    Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
    Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
    Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
    Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of sentinel lymph node failed mapping in endometrial carcinoma patients: a systematic review and meta-analysis.
    Raffone A; Fanfani F; Raimondo D; Rovero G; Renzulli F; Travaglino A; De Laurentiis U; Santoro A; Zannoni GF; Casadio P; Scambia G; Seracchioli R; Mollo A
    Int J Gynecol Cancer; 2023 Jun; 33(6):853-859. PubMed ID: 36914172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Let go of the myth: safety of indocyanine green for sentinel lymph node mapping in endometrial cancer.
    Capasso I; Cucinella G; Volcheck G; McGree M; Fought AJ; Chuzhyk O; De Vitis LA; Schivardi G; Fumagalli D; Occhiali T; Fanfani F; Chiantera V; Scambia G; Reynolds E; Mariani A; Glaser G
    Int J Gynecol Cancer; 2024 Jan; 34(1):80-87. PubMed ID: 38088181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.